Pharmol (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 1.27 Cr
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets -0.60%
About Pharmol (India)
Pharmol (India) Private Limited (PIPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 May 2017 (Seven years and eight months 10 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nanda Kumar and Ramanujula Ramnath serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U15100TG2017PTC117271
-
Company No.
117271
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 May 2017
-
Date of AGM
23 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Pharmol (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nanda Kumar
|
Director | 23-May-2017 | Current |
|
Ramanujula Ramnath
|
Director | 23-May-2017 | Current |
Financial Performance of Pharmol (India).
Pharmol (India) Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmol (India)?
In 2019, Pharmol (India) had a promoter holding of 0.02% and a public holding of 99.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Natems Power Private LimitedRamanujula Ramnath is a mutual person
-
Natems Sugar Private LimitedRamanujula Ramnath is a mutual person
-
Natems Co Gen Private LimitedNanda Kumar and Ramanujula Ramnath are mutual person
-
_PRIVATE_LIMITED.webp)
Natems (Ktk) Private LimitedNanda Kumar and Ramanujula Ramnath are mutual person
-
Vibrant Global Holdings LlpNanda Kumar is a mutual person
-
Nanda Venttures Llp
Nanda Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmol (India)?
Unlock and access historical data on people associated with Pharmol (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmol (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmol (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
